Study raises the standard for measuring nerve cell death

UBC study raises the standard for measuring nerve cell death
Healthy neurons visualized using fluorescent microscopy. Credit: UBC Okanagan

Researchers at UBC's Okanagan campus have developed a new and improved method to judge the effectiveness of experimental therapies for neurodegeneration—the progressive loss of neurons.

"Neurons—or nerve —are hugely important to our daily lives," says post doctoral fellow Aaron Johnstone and study lead author. "These specialized cells collect and process the large amounts of information that enter our bodies via our senses, control our muscles and organs, and form our thoughts and memories. When these cells become unhealthy, it leads to diseases like Alzheimer's and Parkinson's, ALS, glaucoma and chronic pain."

Johnstone says his study uses the first automated test specifically designed for measuring degeneration of grown in a lab.

"The variability in nerve cell lengths, densities and shapes have traditionally made it difficult to reliably analyze their health," says Johnstone. "This, in turn, has generated confusion about the effectiveness of potential pharmacological or genetic treatments."

Using the new approach, which is software-assisted, the research team were able to measure nerve cell densities more accurately.

UBC study raises the standard for measuring nerve cell death
Post doctoral fellow Aaron Johnstone. Credit: UBC Okanagan

To do this the team grew cells in a lab environment, and after establishing healthy researchers mimicked the conditions that cause neurodegeneration. Neuron loss was then captured using fluorescent microcopy—a process that makes the tiny cells easier to see—and analyzed using a computer algorithm.

Johnstone suggests that objective measurement is essential to the process of developing new medicines.

"This procedure makes evaluating new treatment options, like drugs or gene therapies, far more accurate and trustworthy," Johnstone adds.

The study, published in PLOS ONE was supported by funds from the Canadian Institutes of Health Research and the Health Research Fund of Quebec.


Explore further

Autoimmune response drives vision loss in glaucoma

Journal information: PLoS ONE

Citation: Study raises the standard for measuring nerve cell death (2018, August 27) retrieved 26 September 2020 from https://medicalxpress.com/news/2018-08-standard-nerve-cell-death.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
22 shares

Feedback to editors

User comments